IART or MASI: Which Is the Better Value Stock Right Now?
Why Integra LifeSciences (IART) is a Top Momentum Stock for the Long-Term
Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch Nears
Integra LifeSciences Holdings Corporation (IART) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference
Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference
Integra (IART) Upgraded to Buy: What Does It Mean for the Stock?
Integra LifeSciences Holdings Corporation (IART) Q1 2026 Earnings Call Transcript
Integra (IART) Reports Q1 Earnings: What Key Metrics Have to Say
Integra LifeSciences (IART) Beats Q1 Earnings and Revenue Estimates
Integra LifeSciences Reports First Quarter 2026 Financial Results
Integra LifeSciences Announces Leadership Transition
Globus Medical (GMED) Reports Next Week: Wall Street Expects Earnings Growth
Integra LifeSciences (IART) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Is This the Right Time to Hold IART Stock in Your Portfolio?
AxoGen (AXGN) Q1 Earnings Lag Estimates
Here's Why Integra LifeSciences (IART) is a Strong Momentum Stock
Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026
Why Integra (IART) is Poised to Beat Earnings Estimates Again
Integra LifeSciences (NASDAQ:IART) Shares Gap Down Following Analyst Downgrade
Integra LifeSciences Unveils New Real-World Evidence Highlighting PriMatrix® Utilization
Reviewing Integra LifeSciences (NASDAQ:IART) & Sartorius (OTCMKTS:SARTF)
Should You Continue to Hold Integra Stock in Your Portfolio Now?
Integra Q4 Earnings & Revenues Beat Estimates, Margins Down, Stock Up
Why Integra LifeSciences (IART) is a Top Momentum Stock for the Long-Term
Integra LifeSciences Holdings Corporation (IART) Q4 2025 Earnings Call Transcript
Integra (IART) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Integra LifeSciences (IART) Beats Q4 Earnings and Revenue Estimates
Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance
Integra LifeSciences Announces Key Executive Leadership Appointments
Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026
Brokerages Set Integra LifeSciences Holdings Corporation (NASDAQ:IART) Target Price at $15.00
Access Investment Management LLC Lowers Stake in Integra LifeSciences Holdings Corporation $IART
168,000 Shares in Integra LifeSciences Holdings Corporation $IART Purchased by Hussman Strategic Advisors Inc.
3 Undervalued Medical Instrument Stocks Poised to Grow in 2026
Integra LifeSciences Holdings Corporation (IART) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Receives $15.00 Average PT from Brokerages
Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference
Integra LifeSciences Holdings Corporation $IART Shares Sold by Assenagon Asset Management S.A.
Integra LifeSciences Holdings Corporation (IART) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access
AXQ Capital LP Takes Position in Integra LifeSciences Holdings Corporation $IART
Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries
Integra LifeSciences Holdings Corporation (IART) Q3 2025 Earnings Call Transcript
Integra (IART) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Integra LifeSciences (IART) Q3 Earnings Beat Estimates
Integra LifeSciences Reports Third Quarter 2025 Financial Results
Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025
Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting